MSA Team Works Toward Publications
March 16, 2020 MSA has submitted three manuscripts in high impact journals that report the results of pre-clinical experiments evaluating…
First of Three Patents Issued
February 17, 2020 Over the past two years, MSA has worked closely with Bryn Pharma to develop a new system…
On the Move
January 15, 2020 MSA recently made significant upgrades to our office space located within the Frederick Innovation Technology Center. Each…
Mesa Science Associates and Bryn Pharma Announce Initial Study of a New Approach to Treating Anaphylaxis
November 14, 2019 On November 10, 2019, Mr. Michael Mesa, President and CEO of Mesa Science Associates (MSA), announced the…
Bryn Pharma Research on Epinephrine Nasal Spray Presented at The American College of Allergy, Asthma and Immunology Annual Meeting
November 13, 2019 Preclinical Study of Intranasal Epinephrine Administration in Nasal Congestion Model Demonstrated Faster Absorption of Epinephrine in Canines…
Dr. Ken Dretchen Appointed to PhRMA Review Committee
November 9, 2017 Dr. Ken Dretchen, Chief Scientific Officer served as a member of the Basic Pharmacology Advisory Committee for…
MSA at NIH’s Countermeasures Against Chemical Threats (CounterACT) Symposium
June 14, 2017 During the week beginning Sunday 6/11/17 Michael Mesa , President of Mesa Science Associates , will represent…
Mesa Science Associates to join CounterACT Researchers in Boston
April 12, 2017 Mesa Science Associates (MSA) announced today, April 12, 2017 plans to join Counter Act researchers and scientists…
Mesa Science at the National Museum for Health and Medicine
November 8, 2016 Recently, Michael Mesa, MSA President and CEO, was invited by Dr. Adrianne Noe , the curator of…
Dr. Ken Dretchen Appointed to PhRMA Review Committee
November 4, 2016 Dr. Ken Dretchen, Chief Scientific Officer served as a member of the Basic Pharmacology Advisory Committee for…
MSA News
Aug
17,
2021
Thank You MSA
August 13, 2021 – This summer, I was able to intern for Mesa Science Associates (MSA). During my tireless search…
May
13,
2021
Dr. Kenneth Dretchen PhD continues appointment for year 2 as a member of the Pharmaceutical Research and Manufacturers of America (PhRMA) Drug Discovery Research Award Committee
May 2021 This prestigious committee will review grant applications for Pre-doctoral, Post-doctoral and Research Starter Grants dealing with innovative approaches…
Apr
22,
2021
MesaGreen Announces Progress
K9MGP Seizure Program In July 2019, MesaGreen Pharmaceutical (MGP) entered into a research agreement with the University of Minnesota Schools…
